These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24993033)

  • 1. Driving glioblastoma growth by alternative polyadenylation.
    Han T; Kim JK
    Cell Res; 2014 Sep; 24(9):1023-4. PubMed ID: 24993033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
    Masamha CP; Xia Z; Yang J; Albrecht TR; Li M; Shyu AB; Li W; Wagner EJ
    Nature; 2014 Jun; 510(7505):412-6. PubMed ID: 24814343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage factor Im is a key regulator of 3' UTR length.
    Gruber AR; Martin G; Keller W; Zavolan M
    RNA Biol; 2012 Dec; 9(12):1405-12. PubMed ID: 23187700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.
    Kubo T; Wada T; Yamaguchi Y; Shimizu A; Handa H
    Nucleic Acids Res; 2006; 34(21):6264-71. PubMed ID: 17098938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFIm25 regulates human stem cell function independently of its role in mRNA alternative polyadenylation.
    Ran Y; Huang S; Shi J; Feng Q; Deng Y; Xiang AP; Yao C
    RNA Biol; 2022; 19(1):686-702. PubMed ID: 35491945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of CPSF6 leads to global mRNA 3' UTR shortening and enhanced antiviral immune responses.
    Ge Y; Huang J; Chen R; Fu Y; Ling T; Ou X; Rong X; Cheng Y; Lin Y; Zhou F; Lu C; Yuan S; Xu A
    PLoS Pathog; 2024 Feb; 20(2):e1012061. PubMed ID: 38416782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent tumor-specific regulation of alternative polyadenylation of cancer-related genes.
    Xue Z; Warren RL; Gibb EA; MacMillan D; Wong J; Chiu R; Hammond SA; Yang C; Nip KM; Ennis CA; Hahn A; Reynolds S; Birol I
    BMC Genomics; 2018 Jul; 19(1):536. PubMed ID: 30005633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage factor Im (CFIm) as a regulator of alternative polyadenylation.
    Hardy JG; Norbury CJ
    Biochem Soc Trans; 2016 Aug; 44(4):1051-7. PubMed ID: 27528751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
    Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
    Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
    Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
    Masamha CP
    Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of physiological and cancer-related regulators of 3' UTR processing with KAPAC.
    Gruber AJ; Schmidt R; Ghosh S; Martin G; Gruber AR; van Nimwegen E; Zavolan M
    Genome Biol; 2018 Mar; 19(1):44. PubMed ID: 29592812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylation.
    Kim S; Yamamoto J; Chen Y; Aida M; Wada T; Handa H; Yamaguchi Y
    Genes Cells; 2010 Sep; 15(9):1003-13. PubMed ID: 20695905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F mediates enhanced alternative polyadenylation in proliferation.
    Elkon R; Drost J; van Haaften G; Jenal M; Schrier M; Oude Vrielink JA; Agami R
    Genome Biol; 2012 Jul; 13(7):R59. PubMed ID: 22747694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation.
    Burns DM; D'Ambrogio A; Nottrott S; Richter JD
    Nature; 2011 May; 473(7345):105-8. PubMed ID: 21478871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Intronic Polyadenylation by PCF11 Impacts mRNA Expression of Long Genes.
    Wang R; Zheng D; Wei L; Ding Q; Tian B
    Cell Rep; 2019 Mar; 26(10):2766-2778.e6. PubMed ID: 30840896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB.
    Ogami K; Hosoda N; Funakoshi Y; Hoshino S
    Oncogene; 2014 Jan; 33(1):55-64. PubMed ID: 23178487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.